DeepCT vs Rapid PE Triage and Notification (PETN)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepCT

by Deep01 Limited

Rapid PE Triage and Notification (PETN)

by RapidAI (formerly iSchemaView)

AI Verdict

These tools are adjacent competitors, both leveraging AI for rapid detection and triage of critical findings from CT scans in emergency settings. DeepCT focuses on identifying intracranial hemorrhage and other brain abnormalities from non-contrast head CTs. In contrast, Rapid PE Triage and Notification specializes in detecting suspected central pulmonary embolisms from CTPA images, addressing distinct anatomical regions and clinical conditions.

Choose DeepCT if…

Choose DeepCT if your primary need is rapid and accurate AI-powered detection and triage of acute brain pathologies, such as intracranial hemorrhage, acute stroke, or traumatic brain injury, from non-contrast head CT scans. This tool is ideal for emergency departments and neurological units seeking to prioritize critical cases and improve workflow efficiency for time-sensitive brain conditions.

View DeepCT →

Choose Rapid PE Triage and Notification (PETN) if…

Choose Rapid PE Triage and Notification if your focus is on accelerating the identification and management of suspected central pulmonary embolisms using CTPA images. This solution is best suited for institutions aiming to streamline PE care pathways, enable real-time clinician notifications, and improve triage for patients presenting with potential pulmonary embolisms.

View Rapid PE Triage and Notification (PETN) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepCT	Rapid PE Triage and Notification (PETN)
Pricing	Contact for details	Contact for pricing
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based	On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform.
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid PE Triage and Notification (PETN)

Tool B explicitly highlights mobile and desktop application access for real-time notifications and workflow, which is often indicative of a user-friendly design. While Tool A offers PACS integration and web-based access, Tool B's related product reviews suggest an intuitive interface and easy navigation, enhancing overall usability for clinicians.

Clinical Value

DeepCT

Both tools are FDA-cleared and address critical, time-sensitive conditions. However, Tool A (DeepCT) offers a broader range of detection capabilities from a single non-contrast CT scan, including intracranial hemorrhage, acute stroke, TBI, midline shift, fractures, and segmentation/quantification of ICH. This comprehensive analysis for head CTs provides a wider clinical utility compared to Tool B's specialized focus on central pulmonary embolisms.

Pricing & Value

Tie

Both tools have undisclosed, enterprise-level pricing, making a direct comparison of cost and value impossible without further information. While Tool B mentions potential New Technology Add-on Payment (NTAP) reimbursement for related products, this does not provide a direct pricing comparison for the specific PE Triage and Notification tool.

Enterprise Readiness

Rapid PE Triage and Notification (PETN)

Tool B explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for healthcare enterprise adoption. While Tool A's FDA clearance implies adherence to US regulations, its statements regarding BAA and HIPAA compliance are less definitive ('Likely, contact vendor'). Both offer flexible deployment options.

Innovation

Rapid PE Triage and Notification (PETN)

While Tool A offers innovative multi-finding detection for head CTs, Tool B's parent company, RapidAI, has a more extensive and publicly recognized track record of innovation. RapidAI has received multiple awards, including Frost & Sullivan's Global Growth, Innovation & Leadership Award and MedTech Breakthrough Awards, for its AI platforms and products across various neurovascular and vascular conditions, indicating a strong and continuously evolving innovative ecosystem.

Support & Docs

Rapid PE Triage and Notification (PETN)

Tool B (RapidAI) provides clear information about its comprehensive customer support, offering 24/7/365 assistance globally via email and phone. Additionally, RapidAI offers a wealth of educational and support resources, including white papers, webinars, and case studies. Tool A lacks any public information regarding its support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepCT	Rapid PE Triage and Notification (PETN)
Name	DeepCT	Rapid PE Triage and Notification (PETN)
Company	Deep01 Limited	RapidAI (formerly iSchemaView)
Tagline	World-Leading AI-Powered Detection System for Head CT	Accelerate your PE care pathways
Primary Detection Focus	Intracranial Hemorrhage (ICH) and other brain abnormalities	Suspected central pulmonary embolisms (PE)
Specialties	Emergency Medicine, Neurology, Radiology	Cardiology, Emergency Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring DeepCT and Rapid PE Triage and Notification (PETN).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific medical conditions are each of these AI tools designed to detect?

DeepCT is an FDA-cleared AI software for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities, including midline shift, acute stroke, traumatic brain injury (TBI), and fractures, from non-contrast CT scans. Rapid PE Triage and Notification is an FDA-cleared AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms.

How do these tools facilitate workflow prioritization and clinician notification?

Both tools offer worklist prioritization for time-sensitive cases. DeepCT provides notifications to clinicians for suspected findings. Rapid PE Triage and Notification delivers real-time notifications to clinicians via PACS, email, and mobile app.

Beyond initial detection, what additional analytical features do these AI tools offer?

DeepCT provides segmentation and quantification of intracranial hemorrhage (ICH). Rapid PE Triage and Notification includes compressed preview images (not for diagnostic use) and is designed to operate in parallel with the standard of care.

What are the stated compliance and data security assurances for each tool regarding HIPAA and Business Associate Agreements (BAA)?

DeepCT states that HIPAA compliance and a Business Associate Agreement (BAA) are likely, recommending contacting the vendor for specific details. Rapid PE Triage and Notification explicitly states it is HIPAA compliant and has a BAA in place.

Are there specific imaging modalities required for the analysis performed by each tool?

Yes, DeepCT specifically analyzes non-contrast CT scans for brain abnormalities. Rapid PE Triage and Notification is designed to analyze CTPA (Computed Tomography Pulmonary Angiography) images to detect suspected central pulmonary embolisms.